The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| RFL | -28.72% | -91.66% | -39.16% | -71% |
| S&P | +15.06% | +95.03% | +14.29% | +158% |
Rafael Holdings, Inc. owns interest in commercial real estate assets and clinical stage pharmaceutical companies. It operates through the Real Estate and Pharmaceuticals segments. The Real Estate segment refers to the real estate holdings. The Pharmaceuticals segment is comprised of debt interests and warrants in Rafael Pharmaceuticals and a majority equity interest in LipoMedix Pharmaceuticals. The company was founded in 2017 and is headquartered in Newark, NJ.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.36M | 7.7% |
| Gross Profit | $0.26M | 74.5% |
| Gross Margin | 71.82% | 27.5% |
| Market Cap | $51.33M | 30.1% |
| Market Cap / Employee | $1.66M | 0.0% |
| Employees | 31 | 0.0% |
| Net Income | -$4.05M | 93.5% |
| EBITDA | -$5.85M | -83.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $37.94M | 410.2% |
| Accounts Receivable | $0.41M | -6.5% |
| Inventory | 0.3 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.08M | 7.0% |
| Short Term Debt | $0.61M | -73.5% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -21.83% | 7.2% |
| Return On Invested Capital | -40.00% | -7.6% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$3.19M | -751.2% |
| Operating Free Cash Flow | -$3.19M | -1172.1% |
| Metric | Q1 2024 | YoY Change | |||
|---|---|---|---|---|---|
| Price to Earnings | 21.37 | - | |||
| Price to Book | 0.45 | 0.63 | 0.75 | 0.64 | 38.99% |
| Price to Sales | 55.94 | 63.87 | 70.47 | 54.48 | -22.19% |
| Price to Tangible Book Value | 0.46 | 0.57 | 0.75 | 0.60 | 21.23% |
| Enterprise Value to EBITDA | 6.33 | 0.94 | -2.00 | -1.12 | -112.95% |
| Return on Equity | -37.7% | -46.3% | -57.9% | -27.5% | -11.68% |
| Total Debt | $2.31M | $2.39M | $2.39M | $0.69M | -71.07% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
